(1H-Benzoimidazol-2-yl)methanol

Catalog No. :
ACENLG384
CAS No. :
4856-97-7
Molecular Formula :
C8H8N2O
Molecular Weight :
148.16

IUPAC Name:(1H-benzo[d]imidazol-2-yl)methanol

(1H-Benzoimidazol-2-yl)methanol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g97%$54.00Login to see priceIn stockInquiry
500g97%$267.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1H-Benzoimidazol-2-yl)methanol
IUPAC Name(1H-benzo[d]imidazol-2-yl)methanol
MDL No.MFCD00014560
Molecular FormulaC8H8N2O
Molecular Weight148.16
SMILESC1=CC=CC2=C1[NH]C(=N2)CO
InChI KeyIAJLTMBBAVVMQO-UHFFFAOYSA-N
SynonymBB 0219466 | F1011-0474 | FT-0608821 | Piperidine, 4-(1-pyrrolidinyl)- | 2-Benzimidazolemethanol | Q27467558 | Q-101100 | AM20050322 | 2-Hydroxymethyl-Benzoimidazole | AE-641/00568014 | m-Methoxyphenylethanol | AB01097985-03 | 9SZ34H8DY7 | J-800153 | NCGC
CAS No.4856-97-7
PubChem CID78569

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302+H312+H332-H315-H319-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACENLG384 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBXCF471 route compound structure diagram
    ACBXCF4712836-32-0 In Stock
  4. Then
  5. ACENLG384 route product structure diagram
    ACENLG3844856-97-7 In Stock
Inquiry

2. ACENLG384 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACBXCF471 route compound structure diagram
    ACBXCF4712836-32-0 In Stock
  6. Then
  7. ACENLG384 route product structure diagram
    ACENLG3844856-97-7 In Stock
Inquiry

Comments (0)